MICA · CARE LEARNING NOTES
Observe, keep care safe and communicate
Sarcoidosis may remain stable without medication or require prolonged specialist follow-up. Support focuses on breathing, fatigue and quality of life while looking for extrapulmonary symptoms.
Assess the lived impact
Ask what the person can no longer do: walking, stairs, work, sleep and family activities. Where possible, distinguish fatigue from breathlessness in the description without assigning a cause. Substantial fatigue warrants assessment and support; it is not by itself an indication to increase corticosteroids. Encourage suitable activity, rehabilitation when offered and access to psychological support as needed.
[1][2]Recognise findings that change priority
Report new or disproportionate breathlessness, palpitations, presyncope or syncope. Syncope, chest pain or respiratory distress requires the usual urgent assessment. Eye pain or reduced vision needs prompt advice. Also look for new neurological signs. Do not automatically attribute these symptoms to fatigue or established lung disease: a complication or another condition must be considered.
[1][2]Individualised monitoring and treatment safety
Check appointments, lung function tests and prescribed laboratory assessments, including monitoring of affected organs. During treatment, ask about possible infections, sleep problems, weight changes and other experienced effects, then report them. No medication does not mean no follow-up; conversely, treatment should not be continued or stopped without medical review. Avoid unsupervised calcium or vitamin D supplements without advice informed by the assessment.
[1][2]Worsening breathlessness does not always mean pulmonary progression. Palpitations, faintness, syncope or visual decline should be reported as new symptoms. Fatigue may have multiple determinants; describing its practical impact and possible treatment adverse effects helps the team adjust care without premature interpretation.
- Date changes and describe any relationship to exertion or medication.
Make goals and handover explicit
Review the plan’s goal with the person: stability, better breathing, organ protection or improved quality of life. Ask them to describe signs that should prompt contact with the team. Support smoking cessation and activity adjustments without promising cure or an identical course for everyone. Document symptoms compared with baseline, their impact, treatments, measurements and the professional confirming the next steps.
[1][2]A learning situation
FICTIONAL SITUATION · REFLECTION WITHOUT A SCORE
Fictional situation: a patient followed for stable pulmonary sarcoidosis describes a brief loss of consciousness with palpitations during a usual activity.
Can the episode be attributed to chronic fatigue?
Read the reasoning
No. Syncope with palpitations requires urgent medical assessment, including for a cardiac cause without assuming the diagnosis. Make the patient safe, record circumstances and recovery, monitor vital signs and follow the local emergency pathway. Previous pulmonary stability is insufficient reassurance. Hand over medication information and confirm effective transfer of care.
References and scope
- BTS Clinical Statement on pulmonary sarcoidosis (2020 en ligne ; 2021) ↗
- Treating sarcoidosis — patient version of the ERS clinical guideline ↗
Original documentary teaching summary for adult care. Procedures and medicines depend on professional competence, prescription and institutional procedures. International references do not establish an Algerian protocol. Independent human scientific review remains to be confirmed.